<?xml version="1.0" encoding="iso-8859-1"?><?xml-stylesheet href="http://www.congoo.com/css/rss.css" type="text/css" media="screen"?><rss version="2.0"><channel><title>Pharmaceutical-Industry News - Congoo</title><link>http://www.congoo.com/feed/newschannelsfeed.aspx?chid=43&amp;catid=156</link><description>News Feed for - Pharmaceutical-Industry</description><item><title>*XH Guangdong Zhongsheng Pharma (002317.SZ) to open online subscription on Dec.1</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96264451&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-23T01:49:00</pubDate><description>(Xinhua via COMTEX) -- *XH Guangdong Zhongsheng Pharma (002317. SZ) to open online subscription on Dec.1 [ Back To TMCnet.com's Homepage ]</description><source>TMC Net</source></item><item><title>Roxas seeks probe into Pfizer's ban on Avamax</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96252622&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-23T00:31:00</pubDate><description>ROXAS SEEKS PROBE INTO PFIZER'S BAN ON AVAMAX INSISTS DRUGSTORESA MUST SELL CHEAPER MEDICINES Prompted by a complaint of a group of stroke victims that a big drugstore chain has refused to sell a cheap </description><source>Senate of the Philippines</source></item><item><title>Applied Materials, Merck and Braunschweig University Report Receiving Funding by </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96205452&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-23T01:02:00</pubDate><description>(Close-Up Media via COMTEX News Network) -- Applied Materials, Inc., Merck KGaA and the Braunschweig University of Technology announced that they have been awarded a grant by Germany's Federal Ministry </description><source>Quote.com Germany</source></item><item><title>Starpharma Announces $15.6 million Capital Raising</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96261700&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-23T00:45:00</pubDate><description>MELBOURNE, Australia, Nov. 18 /PRNewswire-FirstCall/ -- Starpharma Holdings Limited (ASX: SPL; OTCQX: SPHRY) is pleased to announce a successful capital raising of A$15.6 million through a private placement </description><source>PR Newswire</source></item><item><title>Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96140172&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-23T00:45:00</pubDate><description>- In Preclinical Studies, Peregrine's PS-Targeting Antibodies Including Bavituximab Demonstrated Broad Spectrum Binding to Viruses and Virally Infected Cells Representing Three Viral Hemorrhagic Fever </description><source>PR Newswire</source></item><item><title>Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc.</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=95901021&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-23T00:45:00</pubDate><description>- Continues to Strengthen Integrated Biomarker Capabilities Spanning the Drug Development Continuum - PRINCETON, N.J., Nov. 18 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD), a leading provider of </description><source>PR Newswire</source></item><item><title>MiddleBrook Pharmaceuticals Down 34.3% Since SmarTrend's Sell Rec...</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96247426&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-22T20:51:00</pubDate><description>Company: MiddleBrook Pharmaceuticals Inc (MBRK) SmarTrend, our proprietary pattern recognition system, called a Downtrend for MiddleBrook Pharmaceuticals (NASDAQ:MBRK) on October 13, 2009 at $1.05. Since </description><source>Zibb</source></item><item><title>LoJack Down 3.4% Since SmarTrend's Sell Recommendation</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=95846954&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-22T20:10:00</pubDate><description>Disclaimer: The Connors Group, Inc. ('Company') is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or </description><source>TradingMarkets</source></item><item><title>FBD: Supreme Court issues notice to GlaxoSmithkline for advertising war with Heinz </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96243107&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-22T19:30:00</pubDate><description>â?? An advertising war between two health drink brands Horlicks of GlaxoSmithkline (GSK) and Complan of Heinz India finally found its place in the apex court of India. The Supreme Court of India today </description><source>FoodBizDaily</source></item><item><title>Merck &amp; Co.</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96219548&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-22T07:58:00</pubDate><description>Drug developer Mercks shares gained after a European advisory committee recommended approval for its fertility drug Elonva. The European Medicines Agency panel made the recommendation. If approved by </description><source>Boston Globe</source></item><item><title>JETRO Seminar in India: Investment Opportunities  Japanese Pharmaceutical Market </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96216880&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-22T07:20:00</pubDate><description>Nov. 20, JETRO will host a seminar entitled Investment Opportunities  Japanese Pharmaceutical Market 'Case Studies of Alliances and M&amp;As between India and Japan in Mumbai and Hyderabad, India on December </description><source>JETRO</source></item><item><title>NHI launches new cable management system</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=95986962&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-22T07:06:00</pubDate><description>Oman-based National Heaters Industries (NHI), a leading manufacturer of water heaters and appliances, has announced the launch of their new cable management system, â??Trunking and Traysâ??. Part of the </description><source>Trade Arabia</source></item><item><title>Development of pharmaceutical industry</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96199568&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-22T01:59:00</pubDate><description>Supplying Kazakh people with inexpensive and high-quality medicines is one of the most topical issues today. The countryâ??s president Nursultan Nazarbayev expressed his opinion on this matter during </description><source>Caspio Net</source></item><item><title>FDA Approves Intravenous Formulation Of Pfizer's Revatio(R) (Sildenafil) For The </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96255745&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-22T23:11:00</pubDate><description>Revatio is the Only Treatment in Its Class with Both Oral and Intravenous Formulations NEW YORK--(HSMN NewsFeed)--Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio(R) </description><source>Healthcare Sales &amp; Marketing Network</source></item><item><title>Two pharma cos ready for trials of H1N1 vaccine</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96225108&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-22T18:40:00</pubDate><description>Two pharmaceutical companies have sought permission from the Indian Council of Medical Research to start clinical trials for swine flu vaccine prepared by them using a new method. Ã¢â?¬Å?Cadilla Pharmaceuticals </description><source>The Pioneer</source></item><item><title>A slow, exacting process at Sanofi: H1N1 vaccinemaker opens production facility </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96251394&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-22T22:13:00</pubDate><description>Nov. 22Forget the chicken. At Poconos vaccinemaker Sanofi Pasteur, it all starts with the egg millions of them each week. The key ingredient used to make omelets is also a mini vaccine factory that will </description><source>Pharmacy Choice</source></item><item><title>Bluegreen Down 10.9% Since SmarTrend's Sell Recommendation</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96100758&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-22T19:08:00</pubDate><description>(SmarTrend(R) Spotlight via COMTEX) -- BXG | Quote | Chart | News | PowerRating -- SmarTrend, our proprietary pattern recognition system, called a Downtrend for Bluegreen (NYSE:BXG) on November 03, 2009 </description><source>TradingMarkets</source></item><item><title>University of Wisconsin-Madison - FDA-approved drugs eliminate, prevent cervical </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96247916&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-22T20:58:00</pubDate><description>Learn more about a six-week, no-risk free trial of Virus Weekly We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00. FDA-approved drugs eliminate, prevent </description><source>NewsRX</source></item><item><title>Pfizer's prospects open to debate: Some analysts see strong performance in wake </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96241946&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-22T20:42:00</pubDate><description>(McClatchy-Tribune Informa) Pfizer Inc.'s decision this month to close the former Global Research &amp; Development headquarters in New London is just the latest in a series of downsizings and mergers over </description><source>Individual.com</source></item><item><title>GOP: Frauds in Health Bill</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96191563&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-22T19:43:00</pubDate><description>Calling the Senate health care bill a package that Ponzi schemer "Bernie Madoff would really envy," Republican Sen. Jon Kyl said Sunday that the legislation to be debated in December is long on promises </description><source>FOXNews.com</source></item><item><title>Merck Presents Phase IIb Study Results at AHA Annual Scientific S...</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96051055&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-21T04:27:00</pubDate><description>Company: Merck &amp; Co., Inc. (MRK) In a phase IIb study in 589 patients with primary hypercholesterolemia or mixed hyperlipidemia treated with anacetrapib as monotherapy or co-administered with atorvastatin, </description><source>Zibb</source></item><item><title>Covidien says FDA extends review of opiod pain drug</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96111945&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-21T01:16:00</pubDate><description>-0400 (Reuters Health) * FDA sets Feb. 22, 2010, as new action date * Says FDA needs more time to review additional data BANGALORE (Reuters) - Covidien Plc said U.S. health regulators extended the review </description><source>Reuters Health</source></item><item><title>Roche's Actemra successful in arthritis study</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96066973&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-21T01:16:00</pubDate><description>-0400 (Reuters Health) * Improves symptoms of sJIA after 12 weeks of therapy * Meets primary endpoint in phase III study * EMA rules against Avastin use for aggressive brain cancer * Stock up 0.1 pct </description><source>Reuters Health</source></item><item><title>BRIEF-US FDA panel-Data adequate on Pfizer lung drug safety concerns</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96018456&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-19T20:31:00</pubDate><description>WASHINGTON, Nov 19 (Reuters) - A U.S. Food and Drug Administration advisory panel on Thursday: * Voted 11-1 that data from a trial of Boehringer Ingelheim and Pfizer * Said data from the Spiriva trial </description><source>Forbes.com</source></item><item><title>UPDATE 1-US' GE Capital raises $500 mln in debut Islamic bond</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=95869873&amp;Channel_ID=43&amp;Category_ID=156</link><pubDate>2009-11-19T14:53:00</pubDate><description>DUBAI/ABU DHABI, Nov 19 (Reuters) - A unit of General Electric Co raised $500 million in a 5-year Islamic bond sale, the first by a large U. S. conglomerate, as it looks to diversify its investor base. </description><source>Forbes.com</source></item></channel></rss>